Page 8 - Affinity Technologies News Today

BioAffinity Technologies today announced it appointed Michael Dougherty as chief financial officer, effective immediately.

BioAffinity Technologies (NASDAQ:BIAF – Get Rating) and iSpecimen (NASDAQ:ISPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Profitability This table compares bioAffinity Technologies and iSpecimen’s net margins, […]

31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...

Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time ... | March 31, 2023

BioAffinity Technologies, Inc. today announced the publication of a paper titled “Porphyrin-modified beads for use as compensation controls in flow cytometry” in the peer-reviewed... | March 28, 2023

Conference Call scheduled on April 3, 2023, at 9 a.m. Eastern time ... | March 24, 2023

SUNNYVALE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.30 A.M. ET).In the Green Reunion Neuroscience Inc. (REUN) is up over 67%

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 ...

U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.4...

/PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on bioAffinity Technologies, Inc....